Dual-Hormone Closed-Loop Delivery System Helps Better Than Insulin Pump Therapy in Diabetes

Dual-Hormone Closed-Loop Delivery System Helps Better Than Insulin Pump Therapy in DiabetesIn a recent research, scientists have asserted that dual-hormone closed-loop delivery system is far better than the traditional insulin pump therapy in treating the patients with Type 1 diabetes.

The system is a type of artificial pancreas and is of considerable advantage over the existing system. As per the reports by the Canadian Medical Association, the patients being treated with this system had their glucose regulated with subcutaneous insulin along with subcutaneous miniboluses of glucagon.

The mixture is delivered with help of two fusion pumps. It helps the patients to achieve better glycemic control and lower risk for hypoglycemia. It was learnt that the system considerably lowers down the time spent in hypoglycemia in patients.

“These systems have the potential to substantially improve the management of diabetes and the safety of patients. Patients with hypoglycemia unawareness might benefit most from this technology”, said Haidar et al. They further asserted that 60% of the hypoglycemia cases go unrecognized worldwide.

Type 1 diabetes is severe disease in which the affected person has high levels of glucose in his/her blood. Around 285 million people across the world were diagnosed with the disease in 2010 and the number is expected to rise eventually to 438 million by 2030 with low and middle income countries bearing the highest burden.

Health: 
General: 
Region: 

Advertisements